DiaMedica Therapeutics DMAC is set to give its latest quarterly earnings report on Wednesday, 2024-11-13. Here's what investors need to know before the announcement.
Analysts estimate that DiaMedica Therapeutics will report an earnings per share (EPS) of $-0.16.
The market awaits DiaMedica Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Past Earnings Performance
During the last quarter, the company reported an EPS beat by $0.03, leading to a 3.08% increase in the share price on the subsequent day.
Here's a look at DiaMedica Therapeutics's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.16 | -0.16 | -0.14 | -0.13 |
| EPS Actual | -0.13 | -0.14 | -0.14 | -0.12 |
| Price Change % | 3.0% | -6.0% | -2.0% | 7.000000000000001% |
To track all earnings releases for DiaMedica Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
